The National Institutes of Health (NIH) funds a large portion of the biomedical research in the United States. Biological research helps advance innovation, create cures or treatments for diseases, and positively affects the economy. However, over the past decade funding for NIH has consistently reduced, losing 22% of its funding capacity due to budget cuts, sequestration, and the impact of inflation. This obviously restricts the ability of NIH to provide research grants, which in turn results in fewer biomedical breakthroughs. This kind of pressure on the NIH budget may have been a part of the reason that representatives of the U.S. academic leadership recently attended a White House meeting to discuss the future of NIH and the government’s plans to fund the NIH budget.